Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT07259317 · RECRUITING

Trial details

NCT number: NCT07259317
Sponsor: Corcept Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Carcinoma, Pancreatic Ductal

Start date: 2026-01-27
Primary completion: 2027-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.